共 50 条
- [2] Patisiran in hereditary transthyretin-mediated amyloidosis LANCET NEUROLOGY, 2021, 20 (01): : 21 - 23
- [5] Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S68 - S68
- [7] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis Drugs, 2023, 83 : 1425 - 1432